Search alternatives:
institutions » institution (Expand Search)
Showing 24,121 - 24,140 results of 24,706 for search 'institutions program', query time: 0.27s Refine Results
  1. 24121
  2. 24122
  3. 24123
  4. 24124
  5. 24125
  6. 24126
  7. 24127
  8. 24128
  9. 24129
  10. 24130
  11. 24131
  12. 24132

    Nonregular Physical Activity and Handgrip Strength as Indicators of Fatigue and Psychological Distress in Cancer Survivors by Ilaria Pepe, Alessandro Petrelli, Francesco Fischetti, Carla Minoia, Stefania Morsanuto, Livica Talaba, Stefania Cataldi, Gianpiero Greco

    Published 2025-05-01
    “…Integrating strength assessments and structured physical activity programs may be key strategies in survivorship care to improve mental well-being and overall quality of life.…”
    Get full text
    Article
  13. 24133
  14. 24134
  15. 24135
  16. 24136
  17. 24137
  18. 24138
  19. 24139
  20. 24140

    Synergistic Induction of Immunogenic Cell Death by Biomineralized Manganese and Bisphosphonates Enhances Anti-PD-L1 Therapy in Triple-Negative Breast Cancer by Zhang X, Liu N, Wei M, Yang C, Lin Y, Zeng Y, Li Y, Zhou L, Li T, Zheng Q, Yu H, Zhang J, Gu Y, Xia N, Li S

    Published 2025-04-01
    “…Xiuli Zhang,1,2,* Nan Liu,1,2,* Mingjing Wei,1,2 Chuanlai Yang,1,2 Yanhua Lin,1,2 Yarong Zeng,1,2 Yufang Li,1,2 Lizhi Zhou,1,2 Tingting Li,1,2 Qingbing Zheng,1,2 Hai Yu,1,2 Jun Zhang,1,2 Ying Gu,1,2 Ningshao Xia,1,2 Shaowei Li1,2 1State Key Laboratory of Vaccines for Infectious Diseases, XiangAn Biomedicine Laboratory, School of Public Health, Xiamen University, Xiamen, People’s Republic of China; 2National Institute of Diagnostics and Vaccine Development in Infectious Diseases, State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, Collaborative Innovation Center of Biologic Products, National Innovation Platform for Industry-Education Integration in Vaccine Research, The Research Unit of Frontier Technology of Structural Vaccinology of Chinese Academy of Medical Sciences, Xiamen, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shaowei Li, Email shaowei@xmu.edu.cn Ying Gu, Email guying@xmu.edu.cnBackground: Despite therapeutic benefits of anti-Programmed Death-Ligand 1 (PD-L1) therapy in triple-negative breast cancer (TNBC), low response rates and resistance limit its efficacy. …”
    Get full text
    Article